Scott M. Lippman, M.D.: Short CV

Curriculum Vitae
Scott M. Lippman, M.D.
Page 16
88. Fossella FV, Lee JS, Shin DM, Calayag M, Huber M, Perez-Soler R, Murphy
WK, Lippman SM, Benner S, Glisson B, Chasen M, Hong WK, Raber M. Phase
II study of docetaxel for advanced or metastatic platinum-refractory non-smallcell
lung cancer. J Clin Oncol 13:645-51, 1995 (Reprinted in Classic Papers and
Current Comments: Highlights of Lung Cancer Research. Guest Editor, Einhorn
LH in J Clin Oncol 2:229-36, 1997.
89. Lee JS, Newman RA, Lippman SM, Fossella FV, Calayag M, Raber MN,
Krakoff IH, Hong WK. Phase I evaluation of all-trans-retinoic acid with and
without ketoconazole in adults with solid tumors. J Clin Oncol 13:1501-8, 1995.
90. Lotan R, Xu C, Lippman SM, Ro JY, Lee JS, Lee JJ, Hong WK. Suppression of
retinoic acid receptor beta in oral premalignant lesions and its upregulation by
isotretinoin. N Engl J Med 332:1405-10, 1995.
91. Xu X-C, Lee JS, Lippman SM, Ro JY, Hong WK, Lotan R. Increased
expression of cytokeratins CK8 and CK19 is associated with head and neck
carcinogenesis. Cancer Epidemiol Biomarkers Prev 4:871-6, 1995.
92. Hong WK, Lippman SM, Hittelman WN, Lotan R. Retinoid chemoprevention of
aerodigestive cancer: from basic research to the clinic. Clin Cancer Res 1:677-
86, 1995.
93. Xu X-C, Zile MH, Lippman SM, Lee JS, Lee JJ, Hong WK, Lotan R. Antiretinoic
acid (RA) antibody binding to human premalignant oral lesions, which
occurs less frequently than binding to normal tissue, increases after 13-cis-RA
treatment in vivo and is related to RA receptor beta expression. Cancer Res
55:5507-11, 1995.
94. Perez-Soler R, Fossella FV, Glisson BS, Lee JS, Murphy WK, Shin DM, Kemp
BL, Lee J, Kane J, Robinson RA, Lippman SM, Kurie JM, Huber MH, Raber
MN, Hong WK. Phase II study of topotecan in patients with advanced non-small
cell lung cancer previously untreated with chemotherapy. J Clin Oncol 14:503-
13, 1996.
95. Austin JR, Cebrun H, Kershisnik M, El-Naggar AK, Garden AS, DeMonte F,
Ginsberg LE, Lippman SM, Goepfert H. Olfactory neuroblastoma and
neuroendocrine carcinoma of the anterior skull base: treatment results at the M.
D. Anderson Cancer Center. Skull Base Surg 6:1-8, 1996.
96. Huber M, Lee JS, Newman RA, Fossella FV, Wester M, Hong WK, Lippman
SM. A phase I investigation of the sequential use of methotrexate and paclitaxel
for the treatment of solid tumors. Ann Oncol 7:59-63, 1996.
97. Shin DM, Lee JS, Lippman SM, Lee JJ, Tu ZN, Choi G, Heyne K, Shin HJC, Ro
JY, Goepfert H, Hong WK, Hittelman WN. p53 expression: predicting
recurrence and second primary tumors in head and neck squamous cell
carcinoma. J Natl Cancer Inst 88:519-29, 1996.
98. Garden AS, Lippman SM, Morrison WH, Glisson BS, Ang KK, Geara F, Hong
WK, Peters LJ. Does induction chemotherapy have a role in the management of
nasopharyngeal carcinoma? Results of treatment in the era of computerized
tomography. Int J Radiation Oncology Biol Phys 36:1005-12, 1996.